Sildenafil: a Urologist's View
- 1 January 2000
- journal article
- review article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 16 (sup1), s48-s58
- https://doi.org/10.1185/0300799009117040
Abstract
Erectile dysfunction (ED) is a common problem with a multifactorial aetiology. The treatment of ED has been revolutionised by the introduction of intracavernosal injections some two decades ago. However, the recent development of the orally-administered drug sildenafil (Viagra) has had a major impact on the treatment of ED. We discuss the trials with sildenafil with special reference to cardiovascular risk factors associated with ED.Keywords
This publication has 50 references indexed in Scilit:
- HEALTH OUTCOMES VARIABLES IMPORTANT TO PATIENTS IN THE TREATMENT OF ERECTILE DYSFUNCTIONJournal of Urology, 1998
- Nosologie, épidémiologie, quantification clinique des dysfonctions érectilesLa Revue de Médecine Interne, 1997
- Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitionerJournal of Public Health, 1997
- Prevalence of sexual dysfunction in heterosexual patients attending a central London genitourinary medicine clinicInternational Journal of STD & AIDS, 1997
- Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging StudyJournal of Urology, 1994
- Sexual dysfunction in the diabetic patient with hypertensionThe American Journal of Cardiology, 1988
- The prevalence of diabetic impotenceDiabetologia, 1980
- Diagnostic Value of the Penile Pulse and Blood Pressure: A Doppler Study of Impotence in DiabeticsJournal of Urology, 1975
- Impotence and Diabetes: Histological Studies of the Autonomic Nervous Fibers of the Corpora Cavernosa in Impotent Diabetic MalesDiabetes, 1974
- IMPOTENCE AND DIABETES MELLITUSJAMA, 1958